Artivion, Inc. key statistics and ratios
In fiscal 2025, Artivion, Inc. had return on equity of 2.7%, an operating margin of 7.6%, debt equal to 49.1% of equity and a current ratio of 3.53. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 62.5% | 58.6% | 63.4% | 64.5% | 64.2% | 63.1% | 62.2% | 65.9% | 67.8% | 65.8% | 66.3% | 66.3% | 66.1% | 64.5% | 64.7% | 64.0% | 64.4% | 64.4% |
| Operating margin | 13.0% | 8.5% | 9.7% | 9.6% | 9.8% | 6.1% | 3.7% | 12.1% | 4.2% | 3.5% | 6.2% | 1.0% | 2.7% | 2.0% | 1.6% | 10.0% | 7.6% | 4.4% |
| Net margin | 7.8% | 3.4% | 6.2% | 6.0% | 11.5% | 5.1% | 2.7% | 6.0% | 2.0% | −1.1% | 0.6% | −6.6% | −5.0% | −6.1% | −8.7% | −3.4% | 2.2% | −0.7% |
| Free-cash-flow margin | 13.3% | 16.0% | 11.9% | 12.1% | 8.8% | 2.6% | 5.5% | 7.5% | 2.2% | 1.6% | 2.8% | 2.0% | −5.2% | −5.1% | 2.6% | 2.8% | 0.2% | −1.9% |
| Return on equity | 7.9% | 3.5% | 6.3% | 6.4% | 11.9% | 5.0% | 2.6% | 5.9% | 1.5% | −1.0% | 0.6% | −5.4% | −4.7% | −6.6% | −10.8% | −4.8% | 2.7% | −0.7% |
| Return on assets | — | 2.9% | 5.2% | 5.2% | 9.7% | 4.2% | 2.2% | 4.3% | 0.8% | −0.5% | 0.3% | −2.4% | −1.9% | −2.5% | −3.9% | −1.7% | 1.2% | −0.3% |
| Asset turnover | — | 0.85 | 0.84 | 0.86 | 0.85 | 0.82 | 0.82 | 0.73 | 0.42 | 0.45 | 0.47 | 0.36 | 0.38 | 0.40 | 0.46 | 0.49 | 0.53 | 0.48 |
| Current ratio | — | 5.25 | 3.91 | 3.62 | 5.13 | 5.14 | 5.59 | 4.89 | 4.18 | 5.19 | 4.15 | 3.88 | 5.51 | 4.98 | 4.85 | 4.34 | 3.53 | 3.47 |
| Debt to equity | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 35.2% | 82.6% | 82.1% | 78.1% | 91.3% | 105.6% | 110.7% | 110.7% | 115.9% | 49.1% | 83.0% |
| Interest cover (operating income ÷ interest) | 174.7x | 54.8x | 82.0x | 70.5x | 194.6x | 50.5x | 86.4x | 7.3x | 1.6x | 0.6x | 1.1x | 0.1x | 0.5x | 0.3x | 0.2x | 1.1x | 1.3x | 0.9x |
| Effective tax rate | 39.5% | 45.8% | 35.7% | 34.1% | 30.6% | 15.9% | 31.7% | 41.5% | −4.0% | — | −4.6% | — | — | — | — | — | 33.9% | — |
| R&D as % of revenue | 4.7% | 5.1% | 5.8% | 5.5% | 6.0% | 6.0% | 7.2% | 7.5% | 10.3% | 8.8% | 8.3% | 9.6% | 11.9% | 12.4% | 8.1% | 7.3% | 7.0% | 7.4% |
| SG&A as % of revenue | 44.8% | 42.1% | 47.9% | 49.5% | 48.4% | 51.0% | 51.4% | 50.8% | 53.4% | 53.5% | 51.8% | 55.7% | 56.8% | 50.2% | 59.0% | 46.7% | 51.3% | 54.0% |
| Capital spending as % of revenue | 1.5% | 1.8% | 2.1% | 2.3% | 3.1% | 3.0% | 2.4% | 3.4% | 3.5% | 2.2% | 2.9% | 2.9% | 4.4% | 3.4% | 2.8% | 2.9% | 8.8% | 10.8% |
| Free cash flow ÷ net income | 171.5% | 474.5% | 192.8% | 200.4% | 76.9% | 52.0% | 198.6% | 125.5% | 112.6% | — | 450.9% | — | — | — | — | — | 8.6% | — |
| Dividends ÷ net income | — | — | — | 17.3% | 18.3% | 45.0% | 85.1% | — | — | — | — | — | — | — | — | — | — | — |
| Dividends and buybacks ÷ free cash flow | 2.2% | 31.4% | 21.6% | 29.4% | 36.1% | 233.3% | 42.9% | — | — | — | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 63.7% | 63.2% | 64.2% | 64.7% | 65.6% | 63.1% | 64.9% | 64.0% |
| Operating margin | 4.6% | 2.7% | 2.2% | 7.4% | 11.1% | 9.2% | 5.0% | −6.7% |
| Net margin | −2.4% | −16.9% | −0.5% | 1.2% | 5.7% | 2.1% | 1.2% | −10.7% |
| Free-cash-flow margin | 8.2% | 9.0% | −20.8% | 10.4% | 15.6% | −6.9% | −5.9% | −9.6% |
| Current ratio | 1.88 | 4.34 | 5.53 | 4.78 | 3.93 | 3.53 | 3.86 | 3.47 |
| Debt to equity | 103.0% | 113.8% | 107.0% | 51.3% | 49.0% | 48.0% | 47.8% | 81.6% |
| R&D as % of revenue | 6.9% | 7.6% | 6.8% | 6.3% | 7.1% | 7.9% | 7.6% | 7.2% |
| SG&A as % of revenue | 52.2% | 52.9% | 55.3% | 51.0% | 50.5% | 49.0% | 52.3% | 63.5% |
Financial health
- Short-term assets cover short-term liabilities $371m of assets due within a year against $107m of liabilities due within a year.
- Short-term assets cover long-term liabilities $371m short-term assets against $519m of longer-dated liabilities.
- More cash than debt $77m of cash against $363m of debt.
- Debt below 40% of shareholders' equity Debt is 82% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 102% to 82% over five years.
- A year's operating cash flow covers at least 20% of debt $42m of operating cash flow against $363m of debt.
- Operating profit covers interest at least five times over Operating income of $21m against $24m of interest.
Moat
Weak moat
How hard Artivion's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 1 / 20
Cash operating profit has been a median 2.8% of total assets over 9 years.
- Pricing power 20 / 20
Gross margin has been a median 65.7%, moving by 1.1 percentage points (standard deviation) across 10 years.
- Durability 4 / 20
Operating margin has been a median 4.0%; its worst year was 1.1%.
- Cash conversion 7 / 20
Free cash flow was positive in 6 of 10 years, at a median 1.2% of revenue.
- Discipline 8 / 20
The diluted share count rose 29.2% over five years; stock-based pay has been a median 3.9% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Accuray Inc statistics
- Atricure, Inc. statistics
- Bioventus Inc. statistics
- Inmode Ltd. statistics
- Tactile Systems Technology Inc statistics
Head to head: AORT vs ARAYAORT vs ATRCAORT vs BVS
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies